2 surprising growth stocks trading at bargain valuations

These two companies offer surprising long-term growth potential.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

While a number of companies in a wide range of sectors are obvious growth plays, some stocks elsewhere offer surprisingly strong growth potential. In some cases, this can be shadowed by an underperforming division, or by a previous strategy which did not work as planned. For long-term investors, such companies can be worthwhile buys due to their wide margins of safety. With that in mind, here are two companies which could be worth a closer look right now.

Changing business

Reporting on Friday was healthcare company Smith & Nephew (LSE: SN). Its sales growth in the first quarter of the year was somewhat lacklustre. It increased by 3% on an underlying basis and was flat when the effects of currency translation and asset disposals were included. Beneath this disappointing headline result, however, was a potential catalyst which could push the company’s share price higher.

In recent years, Smith & Nephew has focused to a greater extent on emerging markets. This seems to have been a smart move judging by its performance there in the first quarter of the year. Growth in its Emerging Markets operation was 12% on an underlying basis. This suggests exposure to fast-growing regions where there is a rising and ageing population could spark high earnings growth in the long run.

While Smith & Nephew currently trades on a price-to-earnings (P/E) ratio of 19.8, it has a stable track record of growth. It has delivered rising earnings in four of the last five years. When this stability is combined with its growth potential from emerging markets, it suggests that improved capital gains could be on the horizon. With efficiencies also improving thanks to a new strategy, the company could be a strong performer in an uncertain period for the global economy.

Improving outlook

The 2017 financial year is not expected to have been particularly successful for medical equipment specialist Consort Medical (LSE: CSRT). In fact, its bottom line is forecast to have risen by just 1%, which suggests that its growth rate is running out of steam after four positive years of growth. During that time, the company’s earnings increased at an annualised rate of around 14%, which shows that its strategy was working well.

Looking ahead, the company’s financial performance is expected to improve. In the current financial year, Consort Medical is due to record a rise in earnings of 8%, followed by further growth of 11% next year. This puts it on a price-to-earnings growth (PEG) ratio of only 1.4, which suggests that the market has not yet fully priced-in the company’s upbeat outlook.

As well as impressive growth and value credentials, Consort Medical is also expected to deliver a dividend rise which beats inflation. Its shareholder payouts are forecast to rise by over 5% per annum during the next two years. With dividends covered almost three times by profit, its 2% yield could rise at a brisk pace.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »